APA (7th ed.) Citation

Kirste, I., Hortsch, S., Grunert, V. P., Legault, H., Maglinao, M., Eichenlaub, U., . . . Jochum, S. (2023). Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19. Infectious diseases and therapy, 12(1), 177-191. https://doi.org/10.1007/s40121-022-00711-y

Chicago Style (17th ed.) Citation

Kirste, Imke, Sayuri Hortsch, Veit Peter Grunert, Holly Legault, Maha Maglinao, Udo Eichenlaub, Basel Kashlan, Rolando Pajon, and Simon Jochum. "Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following MRNA-1273 (Spikevax) Vaccination Against COVID-19." Infectious Diseases and Therapy 12, no. 1 (2023): 177-191. https://doi.org/10.1007/s40121-022-00711-y.

MLA (9th ed.) Citation

Kirste, Imke, et al. "Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following MRNA-1273 (Spikevax) Vaccination Against COVID-19." Infectious Diseases and Therapy, vol. 12, no. 1, 2023, pp. 177-191, https://doi.org/10.1007/s40121-022-00711-y.